Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. [PDF]
Stanley IK +9 more
europepmc +1 more source
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study [PDF]
core +1 more source
Variation in serum urate levels in the absence of gout and urate lowering therapy. [PDF]
Shaffer A +4 more
europepmc +1 more source
Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]
Barry A +16 more
europepmc +1 more source
Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis. [PDF]
Klionsky Y +5 more
europepmc +1 more source
Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol. [PDF]
Ofanoa M +8 more
europepmc +1 more source
Allopurinol desensitization with A 2 weeks modified protocol in an elderly patients with multiple comorbidities: a case report [PDF]
core +1 more source
Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study. [PDF]
Eidbo S +7 more
europepmc +1 more source
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. [PDF]
Te Kampe R +8 more
europepmc +1 more source

